This randomised control trial compared the SNOT-22 questionnaires both pre-operatively and three months post-operatively in patients with chronic rhinosinusitis undergoing either FESS or balloon sinuplasty to the maxillary sinus. Forty two patients participated in the study, 21 in each treatment group. There was a subjective improvement in symptoms after surgery in both groups. An objective improvement in the quality of life was seen as a decrease in the total SNOT 22 score. Both balloon sinuplasty and FESS significantly improved all the parameters of the SNOT-22 questionnaire, with no significant difference being found between the two groups. Since no significant difference was found between traditional FESS and balloon sinuplasty in terms of improvement in SNOT-22 parameters, the authors suggest further studies on the cost-benefit of balloon sinuplasty due to its high material costs. It should be noted that this is a short-term study as follow-up with SNOT-22 was at three months post-op only.
Quality of life after FESS or balloon sinuplasty
Top Of Page
Accreditations
Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2024 - Website by Gecko Agency